The ACET chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACET chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACET stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACET Detailed Price Forecast - CNN Money||View ACET Detailed Summary - Google Finance|
|View ACET Detailed Summary - Yahoo! Finance||View ACET Stock Research & Analysis - Zacks.com|
|View ACET Trends & Analysis - Trade-Ideas||View ACET Major Holders - Barrons|
|View ACET Call Transcripts - NASDAQ||View ACET Breaking News & Analysis - Seeking Alpha|
|View ACET Annual Report - CompanySpotlight.com||View ACET OTC Short Report - OTCShortReport.com|
|View ACET Fundamentals - TradeKing||View ACET SEC Filings - Bar Chart|
|View Historical Prices for ACET - The WSJ||View Performance/Total Return for ACET - Morningstar|
|View the Analyst Estimates for ACET - MarketWatch||View the Earnings History for ACET - CNBC|
|View the ACET Earnings - StockMarketWatch||View ACET Buy or Sell Recommendations - MacroAxis|
|View the ACET Bullish Patterns - American Bulls||View ACET Short Pain Metrics - ShortPainBot.com|
|View ACET Stock Mentions - StockTwits||View ACET Stock Mentions - PennyStockTweets|
|View ACET Stock Mentions - Twitter||View ACET Investment Forum News - Investor Hub|
|View ACET Stock Mentions - Yahoo! Message Board||View ACET Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACET - SECform4.com||View Insider Transactions for ACET - Insider Cow|
|View ACET Major Holdings Summary - CNBC||View Insider Disclosure for ACET - OTC Markets|
|View Insider Transactions for ACET - Yahoo! Finance||View Institutional Holdings for ACET - NASDAQ|
|View ACET Stock Insight & Charts - FinViz.com||View ACET Investment Charts - StockCharts.com|
|View ACET Stock Overview & Charts - BarChart||View ACET User Generated Charts - Trading View|
6 Poorly Performing Stocks
Posted on Tuesday March 19, 2019
The return on equity of -211.13% and return on assets of -41.80% are underperforming 84% of companies in the Global Drug Manufacturers - Specialty and Generic industry. The company's largest guru shareholder is Jim Simons (Trades, Portfolio)' Renaissance Technologies with 4.75% of outstanding shares, followed by Chuck Royce (Trades, Portfolio) with 1.53%. The return on equity of -0.71% and return on assets of -0.42% are underperforming 72% of companies in the Global Coal industry.
[$$] Palm Restaurant Family Feud Moves to Bankruptcy Court
Posted on Monday March 11, 2019
The company that holds The Palm Restaurant’s trademarks filed for bankruptcy in a bid to reach a deal over disputed royalty payments among descendants of the 93-year-old steakhouse’s chain’s founders.
[$$] Generic Drug Distributor Aceto Finds Bidder for Subsidiary
Posted on Friday March 08, 2019
Corp., the generic drug distributor that filed for bankruptcy last month, has found a bidder for its subsidiary, Rising Pharmaceuticals Inc. Shore Suven Pharma Inc. has agreed to pay $15 million for Rising and its subsidiaries, Aceto said, subject to higher or better offers at auction.
ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals
Posted on Thursday March 07, 2019
ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into a “stalking-horse” asset purchase agreement with Shore Suven Pharma, Inc. to sell the assets of Rising Pharmaceuticals and Rising’s subsidiaries for gross cash proceeds of $15 million, plus the assumption of operating liabilities and customer obligations related to the acquired business on a cash-free and debt-free basis. Shore Suven Pharma, Inc. is a joint venture between Suven Life Sciences Limited, an India-based provider of contract research and manufacturing services for the global life sciences industry, and Shore Pharma Investments, LLC, a company founded by Vimal Kavuru to acquire generic drug assets.